Deadline approaching for inaugural CIT Accelerator Awards

Beth Walsh | | Health Exec | Artificial Intelligence

Please share your successes in meeting the triple aim!

There are pockets of innovation occurring all throughout the healthcare system. Tell us about your innovative process, solution and successes and your organization could be recognized for its achievement in innovation acceleration. Perhaps you are better tracking diabetic patients, drilling down into data to save money or driving greater care or efficiency by using CDS, analytics or big data? We'll share your project and results to meet the triple aim and help disseminate great ideas that can be adapted by other organizations.

We're extending the deadline but don't wait! You deserve to be recognized.

Access the nomination form here.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Related Content

5 ways AI can help a hospital’s discharge department
When health accessories grow up, they want to be wearable AI
FDA sees promise in new AI model for heart attack detection
ChatGPT exploit could cause data breaches in healthcare, experts warn
Next-generation AI agents are headed for healthcare. What will they do once they get here?
Clinical support tool for pediatric autism earns $27M from private equity

Around the web

Cardiovascular Business
ACC urges RFK Jr. to make Medicare reform a priority, warns against mass layoffs

The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns. 

Radiology Business
FDA announces recall of Medtronic interventional radiology devices after 17 injuries, 4 deaths

One product is being pulled from the market, and the other is receiving updated instructions for use.

AI in Healthcare
What federal regulators can learn from the states about AI oversight

If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?